A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the “REal world dAta in LYmphoma and survival in adults” (REALYSA) cohort
Hervé Ghesquières(Hôpital Lyon Sud), Alain Monnereau(Université de Bordeaux)
Cited by 17
Related Papers
Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers
|American Journal of Hematology|2018|120